This year’s yacht party features a bigger boat, even better food and more decks than you can shake a stick at but there’s one incredibly important new addition.
A fundraiser for the Emily Whitehead Foundation!
Embarking from Hyatt Miami Marina – Thursday 24th January
Boarding: 18:30 – 19:00
Cruising: 19:00 – 22:00
Disembark: 22:00 – 22:30
About the Emily Whitehead Foundation
The Emily Whitehead Foundation is a non-profit that raises awareness and funds for
childhood cancer research. The Foundation aims to provide funding to researchers to develop innovative and less toxic treatments, such as immunotherapy, for pediatric cancer patients. Emily Whitehead is a three-time cancer survivor who is alive today because of CAR-T cell therapy, in fact, Emily was the first child in the world to receive a CAR-T product and, as of May 2018, is six years cancer free.
The Foundation shares Emily’s story to inspire others to take action in the fight against pediatric cancer. We believe in a cure!
In May 2010, at five years old, Emily Whitehead was diagnosed with standard-risk pre-b acute lymphoblastic leukemia (ALL). Typically, this type of leukemia has an 85% to 90% survival rate when treated with standard chemotherapy, radiation and bone marrow transplant. However, many children are resistant to these harsh treatments and relapse, as Emily did in October 2011, and again in February 2012.
Not willing to give up, Emily's parents, Tom and Kari Whitehead, uncovered a CAR-T cell therapy that had just become available at Children’s Hospital of Philadelphia (CHOP). In April 2012, Emily was enrolled in a phase I trial at CHOP and became the first child in the world to receive the therapy and as of May 2018 Emily is six years cancer free.
With Emily’s story gaining attention worldwide, the Whiteheads recognized their opportunity to be advocates and help more patients receive this therapy. In 2015, Tom, Kari and Emily founded the Emily Whitehead Foundation, which raises research funds and awareness for innovative childhood cancer treatments.
Today, the Whiteheads mission is to “Activate The Cure” for all children fighting cancer. They especially support the need for development of less toxic treatment options for pediatric cancer patients, such as the CAR-T cell therapy that saved Emily. This therapy is now approved in the U.S., EU, and Canada to treat patients with relapsed/refractory acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (DLBCL) - and is available in clinical trials in several more locations worldwide.